VORICONAZOLE TEVA NEW

Land: Israel

Sprache: Englisch

Quelle: Ministry of Health

Wirkstoff:

VORICONAZOLE

Verfügbar ab:

TEVA ISRAEL LTD

ATC-Code:

J02AC03

Darreichungsform:

FILM COATED TABLETS

Zusammensetzung:

VORICONAZOLE 200 MG

Verabreichungsweg:

PER OS

Verschreibungstyp:

Required

Hergestellt von:

TEVA ISRAEL LTD, ISRAEL

Therapiebereich:

VORICONAZOLE

Anwendungsgebiete:

Treatment of:Invasive aspergillosis, Fluconazole-resistant serious invasive Candida infections (including C. krusei), Serious fungal infections caused by scedosporium spp. and fusarium spp. Voriconazole Teva should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. Treatment of candidemia in non-neutropenic patients. Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.

Berechtigungsdatum:

2021-12-19

Gebrauchsinformation

PATIENT LEAFLET IN ACCORDANCE
WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) – 1986
The medicine is dispensed with a doctor's
prescription only
Voriconazole Teva New
Film-coated tablets
Composition
Each film-coated tablet contains:
Voriconazole 200 mg
For information regarding inactive ingredients and
allergens, see section 2 “Important information
about some of the ingredients of the medicine” and
section 6 “Additional information”.
Read the entire leaflet carefully before using the
medicine. This leaflet contains concise information
about the medicine. If you have additional questions,
refer to the doctor or the pharmacist.
This medicine has been prescribed for your treatment.
Do not pass it on to others. It may harm them even if
it seems to you that their medical condition is similar.
1. WHAT IS THE MEDICINE INTENDED FOR?
Voriconazole Teva is a broad-spectrum antifungal
medicine intended for the treatment of:
•
Invasive aspergillosis (an infection caused by
fungi of the Aspergillus type).
•
Candida infections in the blood system
(candidemia) in non-neutropenic patients.
•
Invasive Candida infections that are resistant
to fluconazole (another antifungal medicine),
including C. Krusei.
•
Severe fungal infections caused by fungi of the
Scedosporium and Fusarium types.
Voriconazole Teva is intended for patients with
severe, possibly life-threatening, fungal infections.
Voriconazole Teva is intended for the prevention of
invasive fungal infections in high-risk bone marrow
transplant recipients.
Therapeutic class:
Antifungal from the triazole class. It works by killing
or stopping the growth of the different fungi that
cause infections.
2. BEFORE USING THE MEDICINE
Do not use this medicine if:
•
You are sensitive (allergic) to the active
ingredient or to any of the additional ingredients
the medicine contains, see section 6.
•
Do not take this medicine with terfenadine
(for allergy), astemizole (for allergy), cisapride
(for stomach problems), pimozide (for mental
problems), quinidine (for h